|
As we cross the midpoint of 2025, we find ourselves operating in a drastically altered global health and development landscape.
As the landscape continues to evolve in response to shifts in funding priorities and dynamics, the resilience of health systems in low- and middle-income countries (LMICs) is being tested.
In this environment, it is more important than ever that we focus on resilient, efficient, and coordinated approaches to ensure continued access to essential health products.
We recognize that many of our clients and partners are being asked to deliver the same—if not more—health impact with fewer resources.
This moment calls for strategic adaptation: working smarter within constrained budgets while maintaining the quality, reliability, and equity of access to health products and technologies.
We are responding by deepening our support for our clients in several key areas:
-
Streamlining procurement and catalog management processes for both buyers and sellers to help reduce the administrative burdens that have now fallen on their shoulders.
-
Using market assessments to help governments and implementers identify sustainable, long-term sourcing and procurement strategies that are coordinated and cost-effective.
- Engaging with suppliers and manufacturers to shape more responsive and sustainable markets for priority health products.
Further, we are also strengthening our collaboration with local health programs and ministries to help them navigate complex health product markets in order to build national procurement capacity while preventing fragmentation that can divert limited time and funding.
Meanwhile, in the last six months, despite the flux in our sector, we stayed true to our mission of improving access to health products in LMICS and will continue to deliver value to our clients.
Since January 2025, we have delivered more than 1,000 shipments of health products worth more than $145 million to 62 countries.
We also delivered our first shipments of critical products for two new clients.
The first project involves millions of bottles of antibiotics to prevent blindness and mortality in children in Nigeria. Procurement and freight savings have already exceeded $300,000 for this project, with more to come. The second project involves delivering incubators, sample collection kits, and bacterial cultures used in antimicrobial resistance surveillance to select African countries.
We are proud of what we have accomplished in 2025 so far, and later this year, when celebrating our 20th anniversary, we will look back at even more achievements in supply chain excellence.
For now, we continue to be agile, collaborative, and strategic. In doing so, we enable our partners to access products at globally competitive prices and avoid unnecessary transaction costs—ultimately freeing up resources for frontline delivery and patient care.
If your program needs support in health product supply continuity, please get in touch with us.
Let’s continue to focus on making a positive impact on health for those who need it most.
Erin Seidner
PFSCM, Chief Operating Officer & Chief Financial Officer
| 
